The pharmaceutical research and production complex "Velpharm-M" with its own R&D center is the youngest production site of the Velpharm-Group. Velfam-M's production capacity allows for the annual production of up to 6.5 billion dosage units of medicinal products of various therapeutic groups.
The Velpharm-Group is a modern Russian pharmaceutical company from the top 15 Forbes’ list, producing medicinal products in a full cycle: from the substance to the finished product. The holding includes 4 production sites located in Kurgan, Dolgoprudniy and Zelenograd (Moscow): 2 plants for the production of finished medicinal products of various dosage forms and therapeutic groups and 2 sites for the production of API. More than 300 medicinal products are currently represented in the company's product portfolio. 75% of these medicinal products are included in the list of vital and essential drugs. Using the original technology of Velpharm-Group, the full-cycle production of sodium heparin and, based on it, low-molecular heparins, the anesthetic Propofol, and iron-containing antianemic agents has been organized.